Skip to main content
Indian stocks: Visit www.stage2stocks.com →

iHuman Inc. Class A

Stage 4 · Declining · week 41

As of Oct 22, 2026, iHuman is in Stage 4, the downtrend phase, now in week 41 (since Jan 6, 2026). It closed at $1.14, 59.2% below its 52-week high and below its 200-day average, which is falling.

iHuman Inc., together with its subsidiaries, provides an integrated suite of tech-powered intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. More about the company

$1.14
-3.38% today
$58.3M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is IH early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 13w
S4 16w
S2 38w
S4 41w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S3 1w → S2 7w → S4 13w → S1 4w → S4 16w → S1 8w → S4 10w → S1 6w → S2 3w → S3 1w → S4 8w → S1 3w → S2 38w → S3 6w → S4 41w current
Total tracked: 166 weeks across 15 stage runs.

IH among Education & Training Services28th of 43 by relative strength

All 43 →
Stocks in Education & Training Services ranked by relative strength, with stage and one-month change
#StockStageRS1M
1DAOStage 2 · wk 2592+32.4%
2LAURStage 2 · wk 177+5.6%
3APEIStage 4 · wk 676+18.1%
4MHStage 2 · wk 265+7.6%
5LGCYStage 4 · wk 859−1.2%
6AFYAStage 4 · wk 757+9.8%
7STRAStage 2 · wk 1255+4.3%
8FCStage 4 · wk 453+10.1%
…28IHStage 4 · wk 4120−3.4%
vs 52W High
-59.2%
$1.13 lo$2.79 hi
59.2% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 41
1w13w26w
Week 41, extended decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-24.3%
200 DMA: $1.51 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.21x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
→
Short-term trend flat
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-3.4%
3M
-21.1%
6M
-35.2%
YTD
-39.6%
1Y
-57.5%
Scan Membership
Breakout Watch
Latest: 2025-03-04
5 appearances in last 60 days. First seen: 2023-01-13.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 41 · Vol 0.21x
2026-10-21S4
Wk 40 · Vol 0.00x
2026-10-20S4
Wk 40 · Vol 1.11x
2026-10-19S4
Wk 40 · Vol 0.17x
2026-10-16S4
Wk 40 · Vol 0.18x
2026-10-15S4
Wk 40 · Vol 0.96x
2026-10-14S4
Wk 39 · Vol 0.12x
2026-10-13S4
Wk 39 · Vol 0.35x
2026-10-12S4
Wk 39 · Vol 0.28x
2026-10-09S4
Wk 39 · Vol 0.80x
2026-10-08S4
Wk 39 · Vol 0.16x
2026-10-07S4
Wk 38 · Vol 0.53x
Moving averages & range
50 DMA
$1.19
200 DMA
$1.51
52W High
$2.79
52W Low
$1.13
5D Low
$1.14
Resistance levels (recent highs)
20d High
$1.19
60d High
$1.39
120d High
$1.78
250d High
$2.79
Next resistance
+4.4%
to 20d High
P/E (TTM)
19.0
Forward 6.0
ROE
+2.6%
Profit margin +3.1%
Dividend Yield
0.00%
P/B 0.5

iHuman: quick answers

What stage is iHuman in?

As of Oct 22, 2026, iHuman (IH) is in Stage 4, the downtrend phase. It entered Stage 4 on Jan 6, 2026 and is in week 41. What the four stages mean

Is iHuman in an uptrend?

No. iHuman is in a Stage 4 downtrend. It trades 24.3% below its 200-day average, which is falling.

How far is iHuman from its 52-week high?

iHuman closed at $1.14 on Oct 22, 2026, 59.2% below its 52-week high of $2.79. Its 52-week low is $1.13.

How has iHuman performed over the past year?

As of Oct 22, 2026, iHuman is down 57.5% over the past year and down 39.6% so far in 2026.

Which sector and industry is iHuman in?

iHuman is in the Education & Training Services industry, part of the Consumer Staples sector.

About this companyConsumer Staples· Education & Training Services

iHuman Inc., together with its subsidiaries, provides an integrated suite of tech-powered intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Math, iHuman Books, iHuman Stories, iHuman Chinese Classics, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Readers, iHuman Writing, iHuman Fantastic Friends, iHuman AI Coding, and FreeTalk; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, bekids Library, and the Gogo series; Reading Stars; and Aha World and Aha Makeover. It also provides offline products, such as iHuman AI Pal, a plush AI companion; and the iHuman AI Bilingual Early Learning Tablet, an AI-powered smart learning tablet that delivers a bilingual Chinese-English content library for children. In addition, the company offers intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. Further, it engages in the operation of online applications; provision of management and technical consulting; and research and development activities. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.